4.7 Review

The Effect of Walnut Intake on Lipids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Journal

NUTRIENTS
Volume 14, Issue 21, Pages -

Publisher

MDPI
DOI: 10.3390/nu14214460

Keywords

walnuts; dyslipidemia; total cholesterol (TC); triglyceride (TG); low density lipoprotein cholesterol (LDL-C); randomized controlled trials; meta-analysis

Ask authors/readers for more resources

Cardiovascular diseases (CVD) are a leading cause of global death. Walnut intake has been found to improve blood lipid profiles and reduce the risk of CVD. A meta-analysis of 13 trials found that walnut intake was associated with significant reductions in total cholesterol, low-density lipoprotein cholesterol, and triglycerides. Subgroup analysis revealed that overweight/obese individuals and those with comorbidities experienced greater lipid improvements. Longer trial durations led to further improvements. However, extraneous confounding factors and heterogeneity levels may affect the reliability of the results.
Cardiovascular diseases (CVD) are the leading causes of death worldwide. Dyslipidemia is a cardiometabolic risk factor of CVD, yet it can be modifiable. Walnuts have been suggested as a dietary intervention to improve the lipid profile. Therefore, we reviewed the literature to assess the evidence linking walnut intake to the improvement of blood lipids, including total cholesterol (TC), low-density lipoprotein (LDL-C) cholesterol, high-density lipoprotein (HDL-C) cholesterol, and triglycerides (TG). PubMed and Embase databases were searched from 2010 up to March 2022. We limited our search to randomized controlled trials conducted on humans and published in English during the specified period. Cochrane's risk of bias tool for interventional studies was used. A random-effects model was used for the meta-analysis, and weighted mean differences were obtained (WMD) Thirteen trials from the U.S., Europe, and Asia were included. Walnut intake was associated with significant reductions in TC (WMD: -8.58 mg/dL), LDL-C (WMD: -5.68 mg/dL), and TG (WMD: -10.94 mg/dL). Walnut consumption was not associated with HDL-C. Subgroup analysis showed that overweight/obese and those with comorbidities had more lipid improvement. A longer trial duration did result in further improvements. However, our results may be prone to bias due to extraneous confounding factors. Additionally, levels of heterogeneity were considerable for some outcomes of interest. Results from this meta-analysis provide evidence for the health benefits of walnuts on blood lipids. Walnuts possibly reduce the risk of CVD; thus, they can be successfully added to a dietary pattern to enhance health benefits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available